Sensei Biotherapeutics Company
Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.
Technology:
Viral Vectors
Industry:
Viral Vectors
Headquarters:
Gaithersburg, Maryland, United States
Founded Date:
1999-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
10
Total Funding:
58500000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-01-11
Last Funding Type:
Series B
Register and Claim Ownership